Results 81 to 90 of about 118,029,531 (234)
Supplementary Data from Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In ...
Momoko Tokura (14843284) +14 more
core +1 more source
Gene Expression Biomarkers for Breast Ductal Carcinoma in Situ Recurrence Prediction
ABSTRACT Breast ductal carcinoma in situ (DCIS) is often overtreated due to a lack of robust prognostic and predictive tools. This study aimed to evaluate gene expression in a well‐characterised DCIS cohort to determine their clinical utility as biomarkers for ipsilateral recurrence. RNA was extracted from microdissected tissues from primary DCIS.
Alexandria Un +19 more
wiley +1 more source
Case Report: Ductal Carcinoma in Situ Within A Granulomatous Mastitis
Granulomatous lobular mastitis is a rare chronic breast disease, firstly described by Kessler and Wolloch in 1972. In this article we present a 35-yearold patient with granulomatous lobular mastitis and in situ ductal carcinoma and discuss ...
Mine Özşen +2 more
doaj +1 more source
A rare case of extensive ductal carcinoma in situ of the breast with secretory features
We report a very rare case of extensive ductal carcinoma in situ (DCIS) of the breast with secretory features in a 30-year old Japanese woman. The patient presented with a nodule in the lower inner quadrant of the left breast measuring approximately 2-3 ...
Kenichi Sugihara +5 more
doaj +1 more source
ABSTRACT Ductal carcinoma in situ (DCIS) is usually detected with mammography screening and assumed to be a precursor of invasive ductal cancer (IDC) of the breast. Yet, despite an approximately 10‐fold increase in the rate of DCIS detection and treatment within 20 years following implementation of mammography screening in the United States, IDC ...
Ismail Jatoi +4 more
wiley +1 more source
Will ductal carcinoma in situ defeat breast cancer screening?
Gøtzsche and colleagues focus on the inadequacy of patient information leaflets in the NHS breast screening programme.1The failure to disclose information on ductal carcinoma in situ has aptly been described by a patient representative as a “closely ...
JR Benson (7752260)
core
Abbreviated MRI and Ultrafast MRI of the Breast
ABSTRACT Detection of breast cancer in MRI requires fast, dynamic contrast enhanced (DCE) imaging covering the immediate post‐contrast phase, that is, the first 60 s after contrast injection. This ensures selective depiction of invasive cancer as well as DCIS against an otherwise dark background, that is, before background parenchymal enhancement (BPE)
Teresa Lemainque, Christiane K. Kuhl
wiley +1 more source
ABSTRACT Background Accurate preoperative characterization of breast lesions is important for individualized management. The conventional monoexponential (Mono) model has limited ability to capture the complex microstructure of lesions. Non‐Gaussian diffusion models, including continuous‐time random walk (CTRW) and fractional‐order calculus (FROC), may
Yimeng Cao +10 more
wiley +1 more source
Background and purpose: Breast ductal carcinoma in situ with microinvasion (DCIS-MI) is considered to be the interim stage in the progression from breast ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC).
李 爽, 郎冠天, 余科达
doaj
ABSTRACT Tumors are highly heterogeneous, and whole‐lesion radiomics analysis is a popular method for extracting texture features that reflect this heterogeneity, which can be used to build models for cancer diagnosis, staging, therapy response evaluation, and prognosis prediction.
Yang Zhang +2 more
wiley +1 more source

